Source:http://linkedlifedata.com/resource/pubmed/id/14987201
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-2-27
|
pubmed:abstractText |
Cytomegalovirus (CMV) disease is the most common infection following liver transplantation, occurring in approximately 20% of recipients. In liver transplant recipients, CMV is associated with a higher cost following transplantation, subsequent infections, and recurrent hepatitis C. Since we have initiated a prednisone-free immunosuppressive regimen in January 2000, we have noted an extremely low incidence of CMV disease in our cohort of liver transplant recipients. We report our findings here.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1398-2273
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
174-80
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14987201-Adrenal Cortex Hormones,
pubmed-meshheading:14987201-Adult,
pubmed-meshheading:14987201-Cytomegalovirus Infections,
pubmed-meshheading:14987201-Female,
pubmed-meshheading:14987201-Humans,
pubmed-meshheading:14987201-Immunosuppressive Agents,
pubmed-meshheading:14987201-Incidence,
pubmed-meshheading:14987201-Liver Transplantation,
pubmed-meshheading:14987201-Male,
pubmed-meshheading:14987201-Middle Aged,
pubmed-meshheading:14987201-Retrospective Studies,
pubmed-meshheading:14987201-Sirolimus
|
pubmed:year |
2003
|
pubmed:articleTitle |
Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper.
|
pubmed:affiliation |
Division of Gastroenterology/Hepatology Division of Transplant Surgery, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA. James.Trotter@uchsc.edu
|
pubmed:publicationType |
Journal Article
|